Monalizumab Antibody
Monalizumab is a humanized monoclonal antibody targeting the NKG2A immune checkpoint, which blocks inhibitory signaling to enhance NK cell-mediated antitumor activity. Its application in research, particularly for head and neck squamous cell carcinoma (HNSCC), is supported by studies demonstrating its effects in both in vitro immune cell assays and in vivo preclinical models.
Product Specifications
Product Name Alternative
IFNAR, Checkpoint Kinase (Chk)
Target
IFNAR, Chk
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Concentration
10.51 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
147 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
